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Abstract
Background: Fast, specific identification and surveillance of pathogens is the cornerstone of any outbreak
response system, especially in the case of emerging infectious diseases and viral epidemics. This process is
generally tedious and time-consuming thus making it ineffective in traditional settings. The added complexity in
these situations is the non-availability of pure isolates of pathogens as they are present as mixed genomes or
hologenomes. Next-generation sequencing approaches offer an attractive solution in this scenario as it provides
adequate depth of sequencing at fast and affordable costs, apart from making it possible to decipher complex
interactions between genomes at a scale that was not possible before. The widespread application of next-
generation sequencing in this field has been limited by the non-availability of an efficient computational pipeline
to systematically analyze data to delineate pathogen genomes from mixed population of genomes or
hologenomes.
Findings: We applied next-generation sequencing on a sample containing mixed population of genomes from an
epidemic with appropriate processing and enrichment. The data was analyzed using an extensive computational
pipeline involving mapping to reference genome sets and de-novo assembly. In depth analysis of the data
generated revealed the presence of sequences corresponding to Japanese encephalitis virus. The genome of the
virus was also independently de-novo assembled. The presence of the virus was in addition, verified using standard
molecular biology techniques.
Conclusions: Our approach can accurately identify causative pathogens from cell culture hologenome samples
containing mixed population of genomes and in principle can be applied to patient hologenome samples without
any background information. This methodology could be widely applied to identify and isolate pathogen genomes
and understand their genomic variability during outbreaks.
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Findings
Viral pathogens have been a major cause of epidemics
worldwide [1-3]. The regular surveillance system in
many cases of viral epidemics is ineffective to directly
identify the virus unless directed by telltale clinical fea-
tures and clinical complications [4,5]. In many cases the
disease causing pathogen is not identified [6], and con-
tributes to the inadequate and inappropriate
management of the condition. Many of the disease out-
breaks are also caused by changes in the environmental
niche [7], and at least in some cases cause the emer-
gence of new pathogens [6,8-11]. It is estimated that at
least 33 new pathogens have emerged during the last
three decades [12]. Identification of causative organisms
during viral outbreak is a problem, primarily due to the
tedious methods involving isolation and culturing of the
pathogen [13,14]. The relatively low concentration of
the genetic material, especially in the case of RNA
viruses and the heavy interference due to the host cell
nucleic acid and other metagenomes makes sequencing
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depths [15,16].
The availability of next-generation sequencing (NGS)
technology has enabled the scale and ease of addressing
biological questions on a genomics perspective [17,18].
The throughput of sequencing enables deep sequencing
of nucleic acids, adequate to provide for enough reads
of the pathogen, even while the interference of the host
genetic material is very high. Metagenomics has been
one of the major applications of NGS technology for
understanding the composition and dynamics of mixed
population of organisms [19]. The field has now
emerged to a vibrant area of genomics trying to under-
stand a large spectrum of environmental niches right
from human body in both disease as well as healthy
states to natural geographical niches [20,21]. Although
NGS technology has been successfully used for addres-
sing a large diversity of biological questions, its applica-
tion to address questions pertaining to bio-surveillance
and emerging infectious diseases on a large scale has
been limited [22], in spite of the unprecedented oppor-
tunity provided by the scale and speed of operations
[17].
Hologenome, a term borrowed from evolutionary biol-
ogy is defined as the sum of the genetic information of
the host and its microbiota [23]. Hologenomics is an
emerging field in genomics which deals with mixed
population of genomes, as in the case of interacting
populations in host-pathogen and commensals. Holo-
genome differs from the widely popular term Metagen-
ome, which involves the study of communities of
microbes directly in their natural environments [24].
Cultured population of viruses co-exists and interacts
intricately with their host genomes [23]. Although this
presents a technical challenge in isolating individual
genomes from mixed populations, it offers enormous
possibility to understand the interactions and dynamics
between the genomes in real-time.
Here we report the sequencing and analysis methodol-
ogy, involving computational algorithms for reference
mapping and de novo sequence assembly to accurately
identify viral pathogens from mixed populations of gen-
omes. The pipeline relies on the specificity of sequence
mappings and the differential distribution of the mapped
reads across genomes. As a proof of concept, we applied
the methodology on a cell culture hologenome consisting
of human, bacterial and viral genomes, and could specifi-
cally identify the viral pathogen. This methodology could
potentially be applied for rapid and specific identification
of viral pathogens during epidemic outbreaks.
Sample collection and RNA isolation
The sample was collected and isolated during an epi-
demic of acute viral encephalitis from an anonymous
patient suffering from fever and acute encephalitis from
Baba Raghav Das (BRD) Medical College and Nehru
Hospital, Gorakhpur, India. Sample was procured and
processed as per ethical procedures laid down by BRD
Medical College, Gorakhpur, India and National Insti-
tute of Virology, Pune, India. Using standard virus isola-
tion protocols samples were inoculated in human
Rhabdosarcoma (RD) and Baby Hamster kidney (BHK)
cell lines for virus isolation [25,26]. Cells were observed
for cytopathological effects (CPE) and passaged three
times. The cell culture supernatant was filtered using
0.22 μm Millipore filters for every passage. RNA was
isolated using Qiagen (QiaAMP viral RNA minikit) kit
as per manufacturer’s instructions. The RNA was eluted
in 60 μlitre of AVE buffer.
Library preparation, sequencing and genome assembly
The RNA library was prepared according to the manu-
facturer’s instructions using RNA Sample-prep kit (Illu-
mina Inc, USA) for sequencing on Illumina sequencing
platform. Two microgram of total RNA was fragmented
using divalent cation. Cleaved RNA was converted to
cDNA using reverse transcriptase (SSRT-II Invitrogen)
and random primers. The fragments were further sub-
jected to second strand cDNA synthesis using DNA
polymerase as per manufacturer’si n s t r u c t i o n s .E n d -
repairing process followed by A-base addition and adap-
ter ligation was further performed on the cDNA frag-
ments. Approximately 350 base pair products were
separated by gel excision and enriched with PCR to cre-
ate the final library.
Clusters were generated on the flow cell using cBot
Paired end cluster generation kit (Illumina Inc, USA) as
per manufacturer’s instructions. The sequencing runs
were performed on Illumina Inc, USA) using 76 × 2
base reads. The sequence-quality files generated was
transformed to Sanger quality scores using custom
scripts.
The paired end reads were mapped to the reference
datasets using Mapping and Assembly with Qualities
(MAQ) software [27]. The datasets of 3735 viral gen-
omes, 2352 Bacterial genomes and the human genome
corresponding to GRch37/hg19 build was downloaded
from NCBI [28] and used for mapping. The mapped
reads were further analyzed and compared for reads
that overlapped in each reference set. The genomes that
mapped the maximum number of reads post-alignment
were parsed using custom scripts and were further con-
sidered for analysis. Single nucleotide variations and
Insertion Deletion (InDel) events were called using
MAQ scripts. Mappings and functional analysis of the
variations were performed using custom scripts. The
entire pipeline for the data generation and analysis is
summarized in Figure 1.
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rithm based on de Bruijn graphs was used for the de
novo assembly. The entire read data was partitioned into
smaller subsets for analysis. De-novo assembly was
attempted on the subsets with different k-mers. The
data was compiled and compared using in-house scripts.
RT-PCR validation
Experimental validation of the virus was performed
using reverse transcription (RT)-polymerase chain reac-
tion. Specific primer JEV PM1R (reverse primer): 5’-
CGGARTCTCCTGCTTCGCTTGG-3’ and JEV C1F
(forward primer): 5’-GGCAGAAAGCAAAA-
CAAAAGA-3’ specific for Japanese encephalitis virus
were used. RNA was initially reverse transcribed using
JEV PM1R at 50°C using Superscript II reverse tran-
scriptase (Invitrogen, Life Science Technologies). The
cDNA was amplified using forward primer JEV C1F and
reverse primer JEV PM1R. PCR amplification was car-
ried out by denaturing 94°C for 5 min, followed by 35
cycles of 94°C for 30 sec 58°C for 30 sec, 72°C for 1 min
and final extension of 3 min using Taq DNA polymer-
ase (Fermentas).
Results and discussion
We generated approximately 22 million sequence reads
from the cell culture hologenome sample [SRA:
SRX099040]. All reads were 76 bases in paired end
mode, and amounted to a total of 1.67 Gigabases. The
paired-end reads had an average insert size of 350 bases.
The read statistics is available as Additional file 1. The
reads were mapped to Human, 2352 bacteria and 3735
viral genome datasets using Mapping and Assembly
with Qualities (MAQ) with default parameters. Maxi-
mum of two bases mismatching was permitted in the
seed, and the alignments were performed in paired end
mode. All the three alignment files were later trans-
formed and the read headers, which overlap in each of
the sets, were compared using in-house scripts. We
found 2,835,442 reads mapping to the Human genome,
comprising of 13% of the entire reads, 774,056 reads
comprising of 3.6% of the data mapping to the bacterial
reference set, while 10,726,844 mapped to Virus gen-
omes, comprising 49% of the reads (Figure 2a &2b). We
also compared the reads that overlapped in each of the
reference alignment sets. The overlaps were minimal
suggesting specificity of sequence alignments. The reads
mapping to the viral sequence dataset comprising of
3735 complete viral reference genomes were further
analyzed in depth. The analysis revealed that 99% of the
reads mapped to the Japanese encephalitis Virus gen-
ome (Figure 2c). This comprised of over 10 million
reads and provided an effective coverage of over
70,000X over the Japanese encephalitis genome.
Figure 1 Workflow. Summary of the Methodology for viral sample
processing and computational analysis.
Figure 2 Reads mapping and analysis. Mapping and analysis of
reads mapping to reference sequence datasets. (A) The distribution
of reads mapping to each reference dataset. (B) Reads mapping to
each of the three reference datasets and the overlaps between
them. (C) Distribution of reads mapping to the viral reference
datasets. The horizontal axis depicts the 3735 viral genomes while
the vertical axis depicts the reads mapping to each of the viral
genomes. The reads that map to Japanese encephalitis virus was
ordered different from the reads that mapped to the next highest.
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and frugal on compute and memory requirements, how-
ever is limited by the availability of the genome under
consideration in the reference dataset. This could limit
the widespread application of this methodology in iden-
tifying pathogens that have not been sequenced before,
as in the case of new and emerging infectious diseases.
This limitation could be potentially overcome using a de
novo assembly strategy, which does not rely on prior
knowledge of the genome sequence. We therefore
attempted de novo assembly of the cell culture hologen-
ome using Velvet. Different k-mer values and coverage
cut-offs were used for the assembly. The largest contig
was assembled at a k-mer of 27 and had a length of
10,758 bases [GenBank: JN644310]. The de novo
assembled contig aligned with 99% identity to the Japa-
nese encephalitis virus isolate 014178 genome in NCBI
nr database, having a length of 10,976 bases, further
confirming the identity of the virus. We also attempted
to validate the identity of virus using specific reverse
transcriptase PCR (RT-PCR). JE specific primers map-
ping in the C-prM region amplified approximately 400
bp amplicon as expected [25,26], substantiating the
identity of the virus. The data is represented in Addi-
tional file 2.
Furthermore the reads and alignments in the refer-
ence assembly that mapped to Japanese encephalitis
genome were analyzed in depth to understand the gen-
ome organization and genomic variations of the isolate.
We identified a total of 209 genomic variations in the
genome with high confidence. The complete list of
variations, their genomic loci, their type (i.e. synon-
ymous and non-synonymous) and the genes that har-
bor them are summarized in Additional file 3. Fast and
specific identification of viral pathogens would enable
adequate and timely response to disease outbreaks.
Next generation sequencing technology coupled with
efficient computational algorithms could be effectively
used for the identification of pathogens in such
epidemics.
Conclusions
Here we have used next-generation sequencing
approach and generated over 22 million sequence reads
from a cell culture hologenome sample consisting of
human, bacteria and virus. We also successfully applied
a pipeline of computational algorithms including refer-
ence mapping and de novo assembly to identify the
pathogen as Japanese encephalitis virus. Furthermore we
also validated the identity of the virus using RT-PCR
techniques. In summary we successfully demonstrate the
utility of such approaches in identification of viral
pathogens from mixed population of genomes. As
cheaper and faster sequencing technology becomes
widely available in research labs, this approach would
open up immense opportunities in identifying viral
pathogens in outbreaks, apart from being used in regu-
lar bio-surveillance of infectious diseases and screening
for agents used in bioterrorism. This methodology could
also find application in special situations like food pro-
cessing, beverage, and water quality monitoring for iden-
tification of food borne and waterborne pathogens
respectively.
Availability of supporting data
Raw sequence data is available at the NCBI Short Read
Archive with ID: SRX099040. Sequence generated using
de novo genome assembly tools is available at Genbank
with ID: JN644310.
Additional material
Additional file 1: Read Statistics. Excel file containing detailed
information on various read statistics.
Additional file 2: RT-PCR validations. JPG image depicting reverse
transcriptase validation for Japanese encephalitis.
Additional file 3: List of Variations. Microsoft DOC file containing table
on variations identified in Japanese Encephalitis genome (NC_001437).
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